Online Exclusive Article
Decision Making for Cancer Clinical Trial Participation: A Systematic Review
Purpose/Objectives: To describe what is known about the factors that influence cancer clinical trial decision making.
Data Sources: PubMed database and reference lists of identified articles.
Data Synthesis: Variations in research design and methods, including sample characteristics, instrumentation, time between decision made and measurement of decision making, and response rates, have effects on what is known about decision making for cancer clinical trial participation. Communication, whether in the form of education about a cancer clinical trial or as a personal invitation to join, is an important factor influencing decision making. Personal and system factors influence the outcomes of decision making for cancer clinical trials.
Conclusions: The process of decision making for cancer clinical trials is understudied. Nevertheless, the currently available cancer clinical trial decision-making literature suggests a multitude of factors that influence the outcomes of the decision to accept or decline clinical trial participation, as well as the psychosocial consequences of decisional regret, pressures, and satisfaction.
Implications for Nursing: The decision-making process of cancer clinical trials is a fertile area for research and, subsequently, evidence-based interventions. Oncology nurses are in a position to facilitate the process and to relieve the pressures patients perceive regarding decision making for cancer clinical trials that will benefit individuals and, ultimately, society.
Jump to a section
References
Advani, A. S., Atkeson, B., Brown, C. L., Peterson, B. L., Fish, L., Johnson, J. L., … Gautier, M. (2003). Barriers to the participation of African-American patients with cancer in clinical trials. Cancer, 97, 1499-1506. dx.doi.org/10.1002/cncr.11213
Agrawal, M., Grady, C., Fairclough, D. L., Meropol, N. J., Maynard, K., & Emanuel, E. (2006). Patients' decision-making process regarding participation in phase I oncology research. Journal of Clinical Oncology, 24, 4479-4484. dx.doi.org/10.1200/JCO.2006.06.0269
Albrecht, T. L., Eggly, S. S., Gleason, M. E., Harper, F. W., Foster, T. S., Peterson, A. M., … Ruckdeschel, J. C. (2008). Influence of clinical communication on patients' decision making on participation in clinical trials. Journal of Clinical Oncology, 26, 2666-2673. dx.doi.org/10.1200/JCO.2007.14.8114
American Cancer Society. (2009). Cancer facts and figures, 2009. Atlanta, GA: Author.
Avis, N. E., Smith, K. W., Link, C. L., Hortobagyi, G. N., & Rivera, E. (2006). Factors associated with participation in breast cancer treatment clinical trials. Journal of Clinical Oncology, 24, 1860-1867. dx.doi.org/10.1200/JCO.2005.03.8976
Bennett, C. L., Adams, J. R., Knox, K. S., Kelahan, A. M., Silver, S. M., & Bailes, J. S. (2001). Clinical trials: Are they a good buy? Journal of Clinical Oncology, 19, 4330-4339. Retrieved from http://jco.ascopubs.org/content/19/23/4330.long http://jco.ascopubs.org/content/19/23/4330.long
Buss, M. K., DuBenske, L. L., Dinauer, S., Gustafson, D. H., McTavish, F., & Cleary, J. F. (2008). Patient/caregiver influences for declining participation in supportive oncology trials. Journal of Supportive Oncology, 6, 168-174.
Cheng, J. D., Hitt, J., Koczwara, B., Schulman, K. A., Burnett, C. B., Gaskin, D. J., … Meropol, N. J. (2000). Impact of quality of life on patient expectations regarding phase I clinical trials. Journal of Clinical Oncology, 18, 421-428.
Cohen, M. Z., Slomka, J., Pentz, R. D., Flamm, A. L., Gold, D., Herbst, R. S., & Abbruzzese, J. L. (2007). Phase I participants' views of quality of life and trial participation burdens. Supportive Care in Cancer, 15, 885-890. dx.doi.org/10.1007/s00520-007-0216-0
Daugherty, C. K., Fitchett, G., Murphy, P. E., Peterman, A. H., Banik, D. M., Hlubocky, F., & Tartaro, J. (2005). Trusting God and medicine: Spirituality in advanced cancer patients volunteering for clinical trials of experimental agents. Psycho-Oncology, 14, 135-146. dx.doi.org/10.1002/pon.829
DeAngelis, C. D., Drazen, J. M., Frizelle, F. A., Haug, C., Hoey, J., Horton, R., … Van Der Weyden, M. B. (2005). Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors [Editorial]. JAMA, 293, 2927-2929. dx.doi.org/10:1001/jama.293.23.jed50037
de Cenival, M. (2008). [Ethics of research: The freedom to withdraw.] Bulletin de la Societe de Pathologie Exotique, 101, 98-101.
Epstein, R. M., & Street, R. L., Jr. (2007). Patient-centered communication in cancer care: Promoting healing and reducing suffering [Publication 07-6225]. Bethesda, MD: National Cancer Institute.
Ford, J. G., Howerton, M. W., Lai, G. Y., Gary, T. L., Bolen, S., Gibbons, M. C., … Bass, E. B. (2008). Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic review. Cancer, 112, 228-242. dx.doi.org/10.1002/cncr.23157
Gaskin, D. J., Weinfurt, K. P., Castel, L. D., DePuy, V., Li, Y., Balshem, A., … Schulman, K. A. (2004). An exploration of relative health stock in advanced cancer patients. Medical Decision Making, 24, 614-624. dx.doi.org/10.1177/0272989X04271041
Gaston, C. M., & Mitchell, G. (2005). Information giving and decision-making in patients with advanced cancer: A systematic review. Social Science and Medicine, 61, 2252-2264. dx.doi.org/10.1016/j.socscimed.2005.04.015
Gren, L., Broski, K., Childs, J., Cordes, J., Engelhard, D., Gahagan, B., … Marcus, P. (2009). Recruitment methods employed in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Clinical Trials, 6, 52-59. dx.doi.org/10.1177/1740774508100974
Hlubocky, F. J., Ratain, M. J., Wen, M., & Daugherty, C. K. (2007). Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: A study of prognosis, quality of life, and preferences for decision making. Journal of Clinical Oncology, 25, 548-554. dx.doi.org/10.1200/JCO.2005.03.9800
Horstmann, E., McCabe, M. S., Grochow, L., Yamamoto, S., Rubinstein, L., Budd, T., … Grady, C. (2005). Risks and benefits of phase I oncology trials, 1991 through 2002. New England Journal of Medicine, 352, 895-904. dx.doi.org/10.1056/NEJMsa042220
Humber, C. E., Tierney, J. F., Symonds, R. P., Collingwood, M., Kirwan, J., Williams, C., & Green, J. A. (2007). Chemotherapy for advanced, recurrent or metastatic endometrial cancer: A systematic review of Cochrane collaboration. Annals of Oncology, 18, 409-420. dx.doi.org/10.1093/annonc/mdl417
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009). Cancer statistics, 2009. CA: A Cancer Journal for Clinicians, 59, 225-249. dx.doi.org/10.3322/caac.20006
Joffe, S., & Miller, F. G. (2006). Rethinking risk-benefit assessment for phase I cancer trials. Journal of Clinical Oncology, 24, 2987-2990. dx.doi.org/10.1200/JCO.2005.04.9296
Koyfman, S. A., Agrawal, M., Garrett-Mayer, E., Krohmal, B., Wolf, E., Emanuel, E. J., & Gross, C. P. (2007). Risks and benefits associated with novel phase I oncology trial designs. Cancer, 110, 1115-1124. dx.doi.org/10.1002/cncr.22878
Kumar, A., Soares, H. P., Balducci, L., Djulbegovic, B., & National Cancer Institute. (2007). Treatment tolerance and efficacy in geriatric oncology: A systematic review of phase III randomized trials conducted by five National Cancer Institute sponsored cooperative groups. Journal of Clinical Oncology, 25, 1272-1276. dx.doi.org/10.1200/JCO.2006.09.2759
Kurzrock, R., & Benjamin, R. S. (2005). Risks and benefits of phase I oncology trials, revisited. New England Journal of Medicine, 352, 930-932. dx.doi.org/10.1056/NEJMe058007
Lai, G. Y., Gary, T. L., Tilburt, J., Bolen, S., Baffi, C., Wilson, R. F., … Ford, J. G. (2006). Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials. Clinical Trials, 3, 133-141. dx.doi.org/10.1191/1740774506cn143oa
Lara, P. N., Jr., Paterniti, D. A., Chiechi, C., Turrell, C., Morain, C., Horan, N., … Chen, M. S., Jr. (2005). Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. Journal of Clinical Oncology, 23, 9282-9289. dx.doi.org/10.1200/JCO.2005.02.6245
Markman, M., Petersen, J., & Montgomery, R. (2006). Influence of tumor type, disease status, and patient age on self-reported interest regarding participation in cancer clinical trials. Cancer, 107, 849-853. dx.doi.org/10.1002/cncr.21997
Mathews, C., Restivo, A., Raker, C., Weitzen, S., & DiSilvestro, P. (2009). Willingness of gynecologic cancer patients to participate in clinical trials. Gynecologic Oncology, 112, 161-165. dx.doi.org/10.1016/j.ygyno.2008.09.003
Meropol, N. J., Buzaglo, J. S., Millard, J., Damjanov, N., Miller, S. M., Ridgway, C., … Watts, P. (2007). Barriers to clinical trial participation as perceived by oncologists and patients. Journal of the National Comprehensive Cancer Network, 5, 655-664.
Meropol, N. J., Weinfurt, K. P., Burnett, C. B., Balshem, A., Benson, A. B., III, Castel, L., … Schulman, K. A. (2003). Perceptions of patients and physicians regarding phase I cancer clinical trials. Implications for physician-patient communication. Journal of Clinical Oncology, 21, 2589-2596. dx.doi.org/10.1200/JCO.2003.10.072
Mills, E. J., Seely, D., Rachlis, B., Griffith, L., Wu, P., Wilson, K., … Wright, J. R. (2006). Barriers to participation in clinical trials of cancer: A meta-analysis and systematic review of patient-reported factors. Lancet Oncology, 7, 141-148. dx.doi.org/10.1016/S1470-2045(06)70576-9
Moazam, F. (2006). Research and developing countries: Hopes and hypes. Eastern Mediterranean Health Journal, 12(Suppl. 1), S30 S36.
Murthy, V. H., Krumholz, H. M., & Gross, C. P. (2004). Participation in cancer clinical trials: Race-, sex-, and age-based disparities. JAMA, 291, 2720-2726. dx.doi.org/10.1001/jama.291.22.2720
National Cancer Institute. (2009). The nation's investment in cancer research: Connecting the nation's cancer community [Publication No.08-6363]. Bethesda, MD: Author.
National Institutes of Health. (2009). Roadmap for medical research. Retrieved from http://nihroadmap.nih.gov
National Institutes of Health National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. (1979). The Belmont Report: Ethical principles and guidelines for the protection of human subjects of research. Retrieved from http://ohsr.od.nih.gov/guidelines/belmont.html
Nguyen, T. T., Somkin, C. P., Ma, Y., Fung, L. C., & Nguyen, T. (2005). Participation of Asian-American women in cancer treatment research: A pilot study. Journal of the National Cancer Institute. Monographs, 35, 102-105. dx.doi.org/10.1093/jncimonographs/lgi046
Quinn, G. P., Bell, B. A., Bell, M. Y., Caraway, V. D., Conforte, D., Graci, L. B., … Bepler, G. (2007). The guinea pig syndrome: Improving clinical trial participation among thoracic patients. Journal of Thoracic Oncology, 2, 191-196. dx.doi.org/10.1097/JTO.0b013e318031cdb6
Seidenfeld, J., Horstmann, E., Emanuel, E. J., & Grady, C. (2008). Participants in phase I oncology research trials: Are they vulnerable? Archives of Internal Medicine, 168, 16-20. dx.doi.org/10.1001/archinternmed.2007.6
Simon, M. S., Du, W., Flaherty, L., Philip, P. A., Lorusso, P., Miree, C., … Brown, D. R. (2004). Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. Journal of Clinical Oncology, 22, 2046-2052. dx.doi.org/10.1200/JCO.2004.03.005
Stacey, D., Murray, M. A., Legare, F., Sandy, D., Menard, P., & O'Connor, A. (2008). Decision coaching to support shared decision making: A framework, evidence, and implications for nursing practice, education, and policy. Worldviews on Evidence-Based Nursing, 5, 25-35. dx.doi.org/10.1111/j.1741-6787.2007.00108.x
Stacey, D., Samant, R., & Bennett, C. (2008). Decision making in oncology: A review of patient decision aids to support patient participation. CA: A Cancer Journal for Clinicians, 58, 293-304. dx.doi.org/10.3322/CA.2008.0006
Stewart, J. H., Bertoni, A. G., Staten, J. L., Levine, E. A., & Gross, C. P. (2007). Participation in surgical oncology clinical trials: Gender-, race/ethnicity-, and age-based disparities. Annals of Surgical Oncology, 14, 3328-3334. dx.doi.org/10.1245/s10434-007-9500-y
Stryker, J. E., Wray, R. J., Emmons, K. M., Winer, E., & Demetri, G. (2006). Understanding the decisions of cancer clinical trial participants to enter research studies: Factors associated with informed consent, patient satisfaction, and decisional regret. Patient Education and Counseling, 63, 104-109. dx.doi.org/10.1016/j.pec.2005.09.006
Tejeda, H. A., Green, S. B., Trimble, E. L., Ford, L., High, J. L., Ungerleider, R. S., … Brawley, O. W. (1996). Representation of African-Americans, Hispanics, and Caucasians in National Cancer Institute cancer treatment trials. Journal of the National Cancer Institute, 88, 812-816. Retrieved from http://jnci.oxfordjournals.org/content/88/12/812.long http://jnci.oxfordjournals.org/content/88/12/812.long
Todd, A. M., Laird, B. J., Boyle, D., Boyd, A. C., Colvin, L. A., & Fallon, M. T. (2009). A systematic review examining the literature on attitudes of patients with advanced cancer toward research. Journal of Pain and Symptom Management, 37, 1078-1085. dx.doi.org/10.1016/j.jpainsymman.2008.07.009
Travis, K. (2009). Psychosocial oncology research faces uncertain future in UK. Journal of the National Cancer Institute, 101, 777-779. dx.doi.org/10.1093/jnci/djp153
Umutyan, A., Chiechi, C., Beckett, L. A., Paterniti, D. A., Turrell, C., Gandara, D. R., … Lara, P. N., Jr. (2008). Overcoming barriers to cancer clinical trial accrual: Impact of a mass media campaign. Cancer, 112, 212-219. dx.doi.org/10.1002/cncr.23170
Unger, J. M., Coltman, C. A., Jr., Crowley, J. J., Hutchins, L. F., Martino, S., Livingston, R. B., … Albain, K. S. (2006). Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials. Journal of Clinical Oncology, 24, 141-144. dx.doi.org/10.1200/JCO.2005.02.8928
Wagner, L. I., Wenzel, L., Shaw, E., & Cella, D. (2007). Patient-reported outcomes in phase II cancer clinical trials: Lessons learned and future directions. Journal of Clinical Oncology, 25, 5058-5062. dx.doi.org/10.1200/JCO.2007.11.7275
Watanabe, Y., Takahashi, M., & Kai, I. (2008). Japanese cancer patient participation in and satisfaction with treatment-related decision-making: A qualitative study. BMC Public Health, 8, 77. dx.doi.org/10.1186/1471-2458-8-77
Weinfurt, K. P., Depuy, V., Castel, L. D., Sulmasy, D. P., Schulman, K. A., & Meropol, N. J. (2005). Understanding of an aggregate probability statement by patients who are offered participation in phase I clinical trials. Cancer, 103, 140-147. dx.doi.org/10.1002/cncr.20730
Wray, R. J., Stryker, J. E. Winer, E., Demetri, G., & Emmons, K. M. (2007). Do cancer patients fully understand clinical trial participation? A pilot study to assess informed consent and patient expectations. Journal of Cancer Education, 22, 21-24. dx.doi.org/10.1080/08858190701348018